ECG Validation Study

A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 141 participants.

Also called NCT05445726

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; single masking; primary purpose diagnostic
Phase
Phase 2
Enrolled
  • 141 participants (enrolled count) (from the registry)
Sponsor
Analog Device, Inc. (from the registry)
Registry
  • NCT NCT05445726
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05445726. Non-randomized; single masking; primary purpose diagnostic. Start 2022-05-19 (actual); primary completion 2022-09-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
ECG Validation Study
Intervention (Device)
CPM Device
Lead sponsor
Analog Device, Inc. (class: other)
Collaborator
Hope Research Institute (class: not stated)

Record details

Record id
cardio:ct-nct05445726
Content hash
170640963711dc2f0c111c780c4177a3892274f52f6cc85f8c453ac6eb128c8b